Streetbeat News

LUCY

Innovative Eyewear, Inc.

https://www.lucyd.co

Industry

Medical - Instruments & Supplies

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear, Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd.

Open

7.95

Mkt cap

17M

Volume

372K

High

8.12

P/E Ratio

-0.64

52-wk high

27.20

Low

7.00

Div yield

N/A

52-wk low

3.26

On Wednesday, 59 companies hit new 52-week lows. The largest company by market cap to set a new low was Dollar Tree (NASDAQ:DLTR), while the smallest was SenesTech (NASDAQ:SNES). Outlook Therapeutics (NASDAQ:OTLK) saw the biggest fall, with its stock trading down 84.34%. Dollar Tree (NASDAQ:DLTR) had the biggest turnaround, rebounding 0.05% after reaching a new low.

Portfolio Pulse from Benzinga Insights

August 30, 2023 | 5:19 pm

Innovative Eyewear, Inc. (NASDAQ:LUCY, LUCYW) has announced a major update to its Lucyd app, which is the first app to enable ChatGPT on smart eyewear. The company develops smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands.

Portfolio Pulse from Charles Gross

August 14, 2023 | 11:13 am

Innovative Eyewear, Inc. has successfully conducted a secondary offering to raise capital for the launch of smart eyewear collections under its new partnerships with Nautica, Eddie Bauer, and Reebok. The Nautica and Lucyd Safety smart eyewear lines are expected to launch in Q4 2023, while the Eddie Bauer and Reebok lines are expected to launch in early Q1 2024. The company also plans to make further enhancements to the Lucyd app, which powers seamless connection to ChatGPT on all of its eyewear.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:27 pm

Lucyd Eyewear has announced the launch of the Sundrop Collection, which is the world's first eyewear powered by ChatGPT. Following the announcement, the company's shares have seen an upward movement.

Portfolio Pulse from Happy Mohamed

July 25, 2023 | 4:15 pm

The article lists the top 5 oversold health care stocks with an RSI near or below 30, which could lead to significant gains in July. The companies mentioned are Cibus, Inc. (CBUS), Panbela Therapeutics, Inc. (PBLA), Vor Biopharma Inc. (VOR), Innovative Eyewear, Inc. (LUCY), and Bellerophon Therapeutics, Inc. (BLPH). All these stocks have seen a recent dip in their prices.

Portfolio Pulse from Lisa Levin

July 05, 2023 | 12:51 pm

Innovative Eyewear has announced a new retail partnership with PRIVATO Duty-free to create Lucyd Eyewear retail showcases in seven of its airport-based locations. The complete roll-out is expected in Q3 2023.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 11:08 am

U.S. stocks traded mostly higher, with NASDAQ Composite gaining around 100 points. Crude oil prices dropped over 4%. Consumer discretionary shares rose 1.1%, while real estate shares dipped by 1.3%. Root, Inc. shares shot up 39% after receiving a takeover bid. Aeglea BioTherapeutics acquired Spyre Therapeutics and raised $210 million in gross proceeds.

Portfolio Pulse from Lisa Levin

June 22, 2023 | 6:55 pm

Healthcare stocks experienced significant movement during Thursday's intraday session, with gainers including AGLE, TALS, SENS, SHC, SONN, and INKT, while losers were LUCY, ALVR, MNK, AHI, EVLO, and PIII.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:38 pm

Avid Bioservices shares fell 14.1% after issuing FY24 revenue guidance below estimates. Other stocks experienced significant gains and losses during Thursday's mid-day session, with Aeglea BioTherapeutics climbing 422% after acquiring Spyre Therapeutics and securing a $210 million private investment.

Portfolio Pulse from Lisa Levin

June 22, 2023 | 5:09 pm

The Nasdaq Composite gained over 70 points on Thursday, with consumer discretionary shares rising 1.2%. Aeglea BioTherapeutics acquired Spyre Therapeutics and entered into a definitive agreement for a private placement of Series A non-voting convertible preferred stock, resulting in approximately $210 million in gross proceeds.

Portfolio Pulse from Lisa Levin

June 22, 2023 | 4:11 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.